Sections
Shows
Events
Spinal Muscular Atrophy awareness: Treatment advances offer hope to SMA patients
FDA approves $2.1 million Novartis' 'Zolgensma', makes it the costliest drug ever
Swiss drugmaker Novartis wins approval for the most expensive gene therapy treatment
